Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nippon Shinyaku

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nippon Shinyaku's Japan sales performance.

nippon

Biosimilar Remicade reaches market in Japan and India

Biosimilar Remicade reaches market in Japan and India

Biosimilar Remicade reaches market in Japan and India. Nippon Kayaku’ s version of arthritis drug was approved in July. ... In Japan, Nippon Kayaku has launched a biosimilar version of Remicade (infliximab) originally developed by South Korean

Deal Watch table for September 2013

Deal Watch table for September 2013 50. 5. Shin Nippon Biomedical / Transcept Pharma. Licence. TO-2070 nasal powder for acute migraine.

First biosimilar mAb gets the nod in EU

First biosimilar mAb gets the nod in EU In Japan the drug will be co-marketed by Celltrion's development partner Nippon Kayaku.

New formulations of Pralia and Enbrel head list of new drugs in Japan

New formulations of Pralia and Enbrel head list of new drugs in Japan The established version of the drug contained 40mg telmisartan and the same dose of amlodipine, and the line extension - which like its predecessor will be co-promoted by Nippon Boehringer Ingelheim -

Result pages: 1 | 2 | 3 | 4 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics